The Watch What Happens Live host explained his decision to speak openly about his weight loss approach, emphasizing the importance of transparency given his public platform
Tailored Solutions for GLP-1 RA Research for GLP-1 RA Research Whether you're studying weight loss efficacy, glycemic control, cardiovascular outcomes, or quality of life improvements, Signant Health's ePRO solutions deliver: Robust data collection for primary and secondary endpoints Expert input from our team of 50+ clinicians and COA scientists to drive highest quality evidence generation Evidence generation to support for health technology assessments and economic evaluations 24/7 global patient and site support Seamless integration of decentralized trial elements, such as eConsent, TeleVisits, and more
His approach goes beyond medication by integrating nutrition, exercise, and accountability to help patients achieve lasting results
Be aware of potential side effects like nausea, vomiting, and diarrhea, along with TRT-related issues such as fatigue
Women were more likely than men to report decreases in emotional eating (58% vs